Tao, C., Chen, M., Tseng, C., Lapke, N., Chen, S., & Tan, K. T. (2020). Advanced Lung Adenocarcinoma Patient with ERBB2 Amplification Identified by Comprehensive Genomic Profiling Benefits from Trastuzumab. Case Rep Oncol Med.
Citação norma ChicagoTao, Chi-Wei, Mei-Yin Chen, Ching-Min Tseng, Nina Lapke, Shu-Jen Chen, and Kien Thiam Tan. "Advanced Lung Adenocarcinoma Patient With ERBB2 Amplification Identified By Comprehensive Genomic Profiling Benefits From Trastuzumab." Case Rep Oncol Med 2020.
MLA citiranjeTao, Chi-Wei, et al. "Advanced Lung Adenocarcinoma Patient With ERBB2 Amplification Identified By Comprehensive Genomic Profiling Benefits From Trastuzumab." Case Rep Oncol Med 2020.
Opozorilo: Ti citati niso vedno 100% točni.